Concepedia

Luc Pilotte

LP

19

Publications

4.3K

Citations

17

H-Index

2003

Active since

Affiliations

Ludwig Cancer Research(Current)

de Duve Institute

UCLouvain

Walloon Excellence in Lifesciences and Biotechnology

University of Namur

Luc Pilotte is an author at Ludwig Cancer Research specializing in medicine, biochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

2003–2023

19

Publications

19

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove, Luc Pilotte, Ivan Théate et al. · Nature Medicine · 2003 · 2.3K citations

, , +8

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte, Pierre Larrieu, Vincent Stroobant et al. · Proceedings of the National Academy of Sciences · 2012 · 564 citations · Full text

, , +18

Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

Ivan Théate, Nicolas van Baren, Luc Pilotte et al. · Cancer Immunology Research · 2014 · 358 citations

, , +21

Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators

Eduard Dolušić, Pierre Larrieu, Laurence Moineaux et al. · Journal of Medicinal Chemistry · 2011 · 180 citations · Full text

, , +19

Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance

Marc Hennequart, Luc Pilotte, Stefania Canè et al. · Cancer Immunology Research · 2017 · 170 citations

Rows per page

1–5 of 19